Search

CET and skills guides

Study and gain CET points through OT’s online CET exams, and access archived CET, CPD articles and skills guides in our education library

Find out more

Science and vision

News and features about the latest scientific developments and advances in optometry, ophthalmology and eye medicine

Find out more

Professional support

News and features about the latest developments relating to professional support from across optics. This includes updates from optical organisations such as the AOP and the GOC

Find out more

In practice

News and in-depth features about business management and career development in optics

Find out more

Jobs

Explore the latest UK and global jobs in the optical sector for optometrists, dispensing opticians and more

Find out more

Glaucoma: could bone marrow help prevent sight loss?

Scientists are investigating whether bone marrow stem cells could help to limit the loss of retinal ganglion cells in glaucoma patients

bone marrow
Pixabay/Arek Socha

Cardiff University researchers are investigating whether bone marrow stem cells could help to prevent sight loss in glaucoma patients.

Scientists have already demonstrated that transplanting bone marrow stem cells into a model of glaucoma can prevent the death of retinal ganglion cells.

The team now aims to separate exosomes from the bone marrow stem cells to replicate the same benefits without the need for a transplant.

Research lead, Dr Ben Mead, of Cardiff University, shared that the team is working to compare exosomes from different stem cell types to determine which is the most effective and suitable for clinical testing.

“These bone marrow stem cells act as mini factories, secreting many positive factors which behave as protective agents for retinal ganglion cells. If we can isolate these exosome packages and replicate the same therapeutic effects without the need for a transplant, this will not only be a safer approach but it is also more effective as higher doses can be used,” he said.

The research is funded by Fight for Sight, in partnership with Glaucoma UK and Health and Care Research Wales.